RankAlpha logo
Back to Rankings

OABI

OmniAbF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
OABI vs peer average
31/100
OABI vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ABCL is the first available peer comparator.

AbCellera is the clearest public operating comparator because OmniAb names it as technical competition in both genetically engineered rodent discovery and single-cell screening, making it relevant for platform adoption, partner acquisition and discovery-tool differentiation [#10-K-2026-03-04].

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABCLAbCellera Biologics
OABI
OmniAb
ABCL
AbCellera Biologics
Grade
F
F
Momentum
100
99
Value
41
41
Sentiment
0
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs ABCL

OABI / ABCL
Grade Position
Below peers
OABI vs. peer average (F vs. D)
31/100
Momentum
100
OABI
Value
41
OABI
Sentiment
0
OABI

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OABI
1
ABCL
ABCL
F
20/100
Even
2
TWST
TWST
F
20/100
Even
3
KYTX
Kyverna Therapeutics Inc Common
A
100/100
-4
4
CTNM
Contineum Therapeutics Inc Class A Common
D
40/100
-1
5
OVID
Ovid Therapeutics Inc Common
D
40/100
-1
ABCL is the first peer returned for this comparison set.